Securities code: 688321 securities abbreviation: Shenzhen Chipscreen Biosciences Co.Ltd(688321) Announcement No.: 2022-010 Shenzhen Chipscreen Biosciences Co.Ltd(688321)
Application for issuing convertible corporate bonds to unspecified objects
Announcement approved by the Listing Committee of science and Innovation Board of Shanghai Stock Exchange
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
On February 17, 2022, the Listing Committee of the science and Innovation Board of Shanghai stock exchange held the ninth review meeting of the listing committee in 2022 to examine the application of Shenzhen Chipscreen Biosciences Co.Ltd(688321) (hereinafter referred to as “the company”) for issuing convertible corporate bonds (hereinafter referred to as “the issuance”) to unspecified objects. According to the review results of the meeting, the company’s application for this issuance meets the issuance conditions, listing conditions and information disclosure requirements.
The company’s issuance of convertible corporate bonds to unspecified objects this time still needs to comply with the registration procedures of the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”) and can be implemented only after the CSRC makes a decision to approve the registration. The decision of the CSRC to approve the registration and its time are still uncertain. The company will timely perform the obligation of information disclosure according to the progress of the matter and relevant regulations and requirements. Please pay attention to the investment risks.
It is hereby announced.
Shenzhen Chipscreen Biosciences Co.Ltd(688321) board of directors February 18, 2022
